Cromos Pharma
Cromos Pharma is a US-headquartered, privately held international CRO founded in 2004 that delivers integrated clinical trial services — including patient recruitment, regulatory affairs, data management, medical writing, and CTM logistics — to pharmaceutical, biotech, and medical device sponsors across 25+ countries, with regional specialization in Central and Eastern Europe, Central Asia, and Türkiye.
- Company typePrivate
- Founded2004
- HeadquartersUmatilla, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Cromos Pharma does
Cromos Pharma is a US-based, privately held contract research organization (CRO) founded in 2004 by Dr. Vlad Bogin. The company delivers fully integrated clinical research services across all trial phases to pharmaceutical, biotechnology, medical device, and academic sponsors, operating from a US headquarters in Dallas, Texas and a European headquarters in Dublin, Ireland. Service lines span project management and monitoring, patient recruitment and retention, regulatory and EU legal representation, medical writing, biostatistics and data management, clinical trial material (CTM) logistics under ISO 9001:2015 and GDP compliance, pharmacovigilance, and independent GCP audits. The company executes trials across 25+ operating countries with explicit regional specialization in Central and Eastern Europe, Central Asia, and Türkiye, claiming 450+ clinical trials conducted in 70+ indications and 150,000+ patients enrolled across 3,500 trial sites.
The commercial model is professional-services based, delivered through direct enterprise sales with dedicated Business Development Directors and country-level leadership across five Eastern European geographies. Notable commercial and technical differentiators include a trademarked 'No Patients – No Payment™' risk-sharing program that bills sponsors only for enrolled patients, a patented warehouse database program for CTM logistics, a Free Multicountry Feasibility Report used as lead-generation, a CPR (Capability-Plan-Rescue) program for at-risk studies, and a recently launched AI-Powered Clinical Trial Budget Calculator that generates cost estimates from protocol concept in minutes. The company markets itself primarily through content (50+-edition Clinical Research Focus newsletter, blog), conference participation (ASCO, BIO, J.P. Morgan Healthcare Conference, SCOPE, AACR), webinars on EU CTR/CTIS, and a multi-language website.
The business is independently owned with no disclosed outside investors, no parent entity, no subsidiaries, no public listing, and no M&A activity on record. Headcount is in the 101–250 range with reportedly 95% of clinical research professionals holding MDs or PhDs. Revenue, funding, and contract-level financials are not publicly disclosed, leaving the company's absolute scale and growth rates inferable only from operational metrics and CRO industry benchmarks.
Cromos Pharma firmographics
Firmographics- Name
- Cromos Pharma
- Legal name
- Cromos Pharma
- Website
- https://cromospharma.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Cromos Pharma is a US-headquartered, privately held international CRO founded in 2004 that delivers integrated clinical trial services — including patient recruitment, regulatory affairs, data management, medical writing, and CTM logistics — to pharmaceutical, biotech, and medical device sponsors across 25+ countries, with regional specialization in Central and Eastern Europe, Central Asia, and Türkiye.
- Ownership category
- akta.pro rank
Cromos Pharma industry classification
Industry- Product category
- Contract Research Organization (CRO) Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)
Keywords
Where Cromos Pharma is headquartered
LocationHeadquarters
- HQ city
- Umatilla
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Cromos Pharma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Clinical Research Services: Full-service CRO providing integrated clinical research solutions including project management, monitoring services, and clinical research services across all trial phases.
- Regulatory Services: Regulatory support including compilation of initial documents, review of IC documentation, obtaining trial subject insurance, secure import/export licenses, and regulatory submissions.
- Patient Recruitment Services: Patient recruitment and retention services with promotional and educational materials, DTC outreach, and investigator materials.
- Data Management and Biostatistics: Comprehensive data management including CRF development, database design, double data entry, SAS programming, and data transfers.
- Medical Writing: Medical writing services including study protocols, investigator brochures, patient informed consent forms, and clinical study reports.
- CTM Logistics: Clinical trial material logistics including warehousing, storage, 24/7 receipt of IMP and CTM, with compliance to ISO 9001:2015 and GDP.
- Pharmacovigilance Support: PV support with therapeutic excellence, QPPV team for EU registered products, and tailored safety solutions.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Cromos Pharma product offering
Product offeringCore offering
Cromos Pharma is a US-based, ISO-accredited international Contract Research Organization (CRO) providing integrated clinical research services across all trial phases for pharmaceutical, biotech, and medical device sponsors. Its service portfolio spans patient recruitment and retention, regulatory support, EU legal representation, medical writing, biostatistics and data management, clinical trial material (CTM) logistics, pharmacovigilance, and independent audits. The company differentiates commercially through its trademarked "No Patients – No Payment™" risk-sharing program and operationally through an AI-Powered Clinical Trial Budget Calculator and a patented CTM warehouse database program.
Product overview
Cromos Pharma is a US-based, ISO-accredited international Contract Research Organization (CRO) delivering fully integrated clinical research solutions across all trial phases. The company's portfolio centers on its core Clinical Trial Budget Calculator—an AI-powered tool for cost estimation—alongside comprehensive service modules including Patient Recruitment and Retention, Clinical Research Services, Regulatory Support, EU Legal Representation, Medical Writing, Biostatistics and Data Management, CTM Logistics, Pharmacovigilance Support, and Independent Audits. A key differentiator is the 'No Patients – No Payment™' risk-sharing program. The platform operates across 25+ countries with expertise in Central and Eastern Europe, Central Asia, and Türkiye, having conducted 450+ clinical trials enrolling 150,000+ patients across 3,500 trial sites.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Research Services
- Patient Recruitment and Retention Services Comprehensive patient recruitment and retention services including promotional and educational materials, direct-to-consumer outreach, investigator's materials, booster visits, referral sites, and patient commitment programs.
- Regulatory Support Services Regulatory services including compilation of initial documents for Regulatory Authorities and ECs/IRBs, IC documentation review, trial subject insurance, import/export licenses, regulatory strategy, and agency submissions.
- EU Legal Representation Services Legal gateway to Europe providing legal representation in EU/EEA, QP statement obtainment, and cost-effective regulatory compliance services for sponsors without a local EU entity.
- Medical Writing Services Medical writing deliverables including study concepts, clinical study protocols and amendments, statistical analysis plans, Investigator Brochures, IMP Dossiers, Patient Informed Consent Forms, Clinical Study Reports, and publication materials.
- Biostatistics and Data Management Services Data management and biostatistics services including CRF development and validation, database design, double data entry, SAS programming, data validation, and data transfers.
- CTM Logistics Services Full-scope clinical trial material logistics including controlled access storage, 24/7 receipt of IMP and CTM, a patented warehouse database program, and GDP- and ISO 9001:2015-compliant distribution.
- Pharmacovigilance (PV) Support Services Pharmacovigilance support with therapeutic, technical, and operational excellence, including tailored safety solutions, a QPPV team for EU-registered products, regulatory compliance, and pharmacovigilance consultancy.
- Independent Audits Services Independent audit services including clinical site GCP audits, documentary Trial Master File audits, system vendor audits, and regulatory inspection readiness support.
- Rescue and Turnaround Services Rescue and turnaround services providing comprehensive recovery plans for studies behind schedule or encountering patient recruitment difficulties, ensuring investments yield return and studies meet timelines.
- Clinical Trial Budget Calculator AI-powered tool developed by Cromos Pharma's expert team that enables sponsors to estimate clinical trial costs, moving from protocol concept to cost clarity in minutes.
- No Patients – No Payment™ Program Trademarked risk-sharing program where sponsors pay only for enrolled patients and not for dormant, non-recruiting sites, aligning Cromos Pharma's incentives with sponsor enrollment success.
Quantifiable outcome
- 450+ clinical trials conducted in 70+ indications
- +2 more outcomes
Companies that use Cromos Pharma
Customer profileSegments4 records
Ideal customer profiles4 records
Cromos Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature4 records
Cromos Pharma partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Cromos Pharma competitors and assessment
Company assessmentDirect peers
- Medpace Holdings: Mid-sized, science-focused clinical CRO offering full-service Phase I-IV trial management for pharma and biotech — the closest publicly-traded analog to Cromos Pharma's full-service, scientifically-deep operating model.
- Worldwide Clinical Trials: Mid-market CRO focused on complex therapeutic areas in Phase II-IV trials with strong biometrics and patient recruitment — directly comparable to Cromos's full-service offering and CEE/biotech client profile.
- Premier Research: Specialty mid-size CRO with particular strength in oncology, rare disease, and pediatric trials; closely matches Cromos's therapeutic-area focus and biotech sponsor concentration.
- Advanced Clinical: Mid-tier clinical CRO providing full-service trial management for biotech and pharma sponsors, similar in scale to Cromos with overlapping therapeutic-area and patient recruitment capabilities.
- Rho: Mid-sized, science-driven CRO with full-service clinical operations and biometrics for small/mid-cap biopharma — directly comparable in scale, scientific talent emphasis, and service breadth.
- Clinipace Worldwide: Mid-size tech-enabled CRO with global operational reach in oncology, cardiovascular, and rare disease; positioned similarly to Cromos for biotech sponsors and adaptive trial designs.
Broad incumbents
- IQVIA: Largest global CRO/clinical technology provider combining clinical operations with real-world data and analytics; competes for enterprise CRO contracts as a broad portfolio incumbent.
- ICON plc: Global top-5 CRO with full-service clinical trial management, post-2021 expansion via PRA acquisition — competes for the same enterprise CRO mandates as Cromos at much larger scale.
Regional players
- Clinart: Eastern European CRO with regional hubs and global trial experience; competes head-to-head with Cromos for CEE-rooted studies and biotech sponsors targeting European patient access.
- OCT Clinical: CRO historically focused on Central and Eastern Europe with multi-country trial execution; the most direct geographic competitor to Cromos in its core CEE operating footprint.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Cromos Pharma social profiles
Digital presenceCromos Pharma compliance and trust
Trust signalCompliance2 records
Cromos Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cromos Pharma leadership team
Management profileNumber of profiles
Profiles9 records
Cromos Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cromos Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cromos Pharma
What does Cromos Pharma do?
Cromos Pharma is a US-based, ISO-accredited international Contract Research Organization (CRO) providing integrated clinical research services across all trial phases for pharmaceutical, biotech, and medical device sponsors. Its service portfolio spans patient recruitment and retention, regulatory support, EU legal representation, medical writing, biostatistics and data management, clinical trial material (CTM) logistics, pharmacovigilance, and independent audits. The company differentiates commercially through its trademarked "No Patients – No Payment™" risk-sharing program and operationally through an AI-Powered Clinical Trial Budget Calculator and a patented CTM warehouse database program.
Is Cromos Pharma a public or private company?
Cromos Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Cromos Pharma founded?
Cromos Pharma was founded in 2004. It employs 101 to 250 people.
Where is Cromos Pharma based?
Cromos Pharma is headquartered in Umatilla, United States, in the North America region.
How does Cromos Pharma make money?
Seven revenue lines are on record. Clinical Research Services are the primary driver. The others are regulatory Services, patient Recruitment Services, data Management and Biostatistics, medical Writing, CTM Logistics and pharmacovigilance Support.
Who are Cromos Pharma's main competitors?
Direct peers on record are Medpace Holdings, Worldwide Clinical Trials, Premier Research, Advanced Clinical, Rho and Clinipace Worldwide. Broad incumbents are IQVIA and ICON plc. Regional players are Clinart and OCT Clinical.
Does Cromos Pharma have an API?
No public API is recorded for Cromos Pharma.
What industry is Cromos Pharma in?
Cromos Pharma's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 5417 and its SIC code is 8742.